Related references
Note: Only part of the references are listed.The C-terminal transmembrane domain of Bcl-x(L) mediates changes in mitochondrial morphology
Jing-Yi Zheng et al.
BIOPHYSICAL JOURNAL (2008)
Phosphorylation of Bcl-xL after spinal cord injury
Diana M. Cittelly et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways
N Watanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines
S Simizu et al.
CANCER RESEARCH (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
K Gumireddy et al.
CANCER CELL (2005)
Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction
LH Du et al.
ONCOGENE (2005)
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFβ-TrCP
N Watanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance
S Simizu et al.
CANCER SCIENCE (2004)
Bcl-2 family members: intracellular targeting, membrane-insertion, and changes in subcellular localization
A Schinzel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Structural biology of the Bcl-2 family of proteins
AM Petros et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria
Y Tamura et al.
FEBS LETTERS (2004)
The anticancer natural product pironetin selectively targets Lys352 of α-tubulin
T Usui et al.
CHEMISTRY & BIOLOGY (2004)
Polo-like kinases and the orchestration of cell division
FA Barr et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Bcl-xL sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers
SY Jeong et al.
EMBO JOURNAL (2004)
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
AH Ree et al.
ONCOGENE (2003)
The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain
AEH Elia et al.
CELL (2003)
Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate
H Nakajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashion
M Kawatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
XQ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis
A Basu et al.
FEBS LETTERS (2003)
Characterization of the signal that directs Bcl-xL, but not Bcl-2, to the mitochondrial outer membrane
T Kaufmann et al.
JOURNAL OF CELL BIOLOGY (2003)
Bcl-XL deamidation is a critical switch in the regulation of the response to DNA damage
BE Deverman et al.
CELL (2002)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Apoptosis-based therapies
JC Reed
NATURE REVIEWS DRUG DISCOVERY (2002)
Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines
S Simizu et al.
NATURE CELL BIOLOGY (2000)
Bcl-2 family: Life-or-death switch
Y Tsujimoto et al.
FEBS LETTERS (2000)
Share Paper
